Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Neurology|June 17, 2026
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very OldChiara Ceriello, Olga H Torres, Sara Rubio-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJesús Garcia Castro, Lídia Vaqué-Alcázar, Lawren VandeVrede, et al.
Ebiomedicine|September 19, 2024
Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinicAmanda Cano, María Capdevila, Raquel Puerta, et al.
Brain : a Journal of Neurology|April 17, 2025
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuumBenjamin J Buehner, Alejandra O Morcillo-Nieto, Sara E Zsadanyi, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's diseaseStephanie M Grasso, Wenfu Bao, Sonia Karin Marqués-Kiderle, et al.
Frontiers in Aging Neuroscience|July 6, 2026
The predictive power of neuropsychological measures in MCI: early detection of dementia conversionConcepcion Padilla, Sara E Zsadanyi, Irina Aragón, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2019
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD studyAlberto Lleó, Daniel Alcolea, Pablo Martínez-Lage, et al.
Ebiomedicine|April 1, 2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort studyLaia Montoliu-Gaya, Daniel Alcolea, Nicholas J Ashton, et al.
Nature Communications|July 2, 2025
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s diseaseLaia Montoliu-Gaya, Shijia Bian, Eric B Dammer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's diseaseAlexander Maximilian Bernhardt, Íñigo Rodríguez-Baz, Iban Aldecoa, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Neurology|June 17, 2026
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very OldChiara Ceriello, Olga H Torres, Sara Rubio-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJesús Garcia Castro, Lídia Vaqué-Alcázar, Lawren VandeVrede, et al.
Ebiomedicine|September 19, 2024
Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinicAmanda Cano, María Capdevila, Raquel Puerta, et al.
Brain : a Journal of Neurology|April 17, 2025
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuumBenjamin J Buehner, Alejandra O Morcillo-Nieto, Sara E Zsadanyi, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's diseaseStephanie M Grasso, Wenfu Bao, Sonia Karin Marqués-Kiderle, et al.
Frontiers in Aging Neuroscience|July 6, 2026
The predictive power of neuropsychological measures in MCI: early detection of dementia conversionConcepcion Padilla, Sara E Zsadanyi, Irina Aragón, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2019
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD studyAlberto Lleó, Daniel Alcolea, Pablo Martínez-Lage, et al.
Ebiomedicine|April 1, 2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort studyLaia Montoliu-Gaya, Daniel Alcolea, Nicholas J Ashton, et al.
Nature Communications|July 2, 2025
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s diseaseLaia Montoliu-Gaya, Shijia Bian, Eric B Dammer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's diseaseAlexander Maximilian Bernhardt, Íñigo Rodríguez-Baz, Iban Aldecoa, et al.
Pageof 25